公式動画ピックアップ

AAPL   ADBE   ADSK   AIG   AMGN   AMZN   BABA   BAC   BL   BOX   C   CHGG   CLDR   COKE   COUP   CRM   CROX   DDOG   DELL   DIS   DOCU   DOMO   ESTC   F   FIVN   GILD   GRUB   GS   GSK   H   HD   HON   HPE   HSBC   IBM   INST   INTC   INTU   IRBT   JCOM   JNJ   JPM   LLY   LMT   M   MA   MCD   MDB   MGM   MMM   MSFT   MSI   NCR   NEM   NEWR   NFLX   NKE   NOW   NTNX   NVDA   NYT   OKTA   ORCL   PD   PG   PLAN   PS   RHT   RNG   SAP   SBUX   SHOP   SMAR   SPLK   SQ   TDOC   TEAM   TSLA   TWOU   TWTR   TXN   UA   UAL   UL   UTX   V   VEEV   VZ   WDAY   WFC   WK   WMT   WORK   YELP   ZEN   ZM   ZS   ZUO  

  公式動画&関連する動画 [ノバルティス NVS]  (ランダムに表示)

2021 NSofT Symposium: Rostom Ahmed-Belkacem, PhD
Novartis   2021-07-11 に公開
  Postdoctoral research scientist Rostom Ahmed-Belkacem of the Institute of Biomolecules Max Mousseron at the University of Montpellier presents “Dinucleosides S-adenosyl-L   ...more
2021 NSofT Symposium: Christine Kreuder Johnson, VMD, PhD, Keynote
Novartis   2021-07-11 に公開
  In the symposium’s closing keynote, “Emerging pandemic threats in an era of accelerated global change,” Christine Kreuder Johnson -- Director of the EpiCenter for Disease   ...more
2021 NSofT Symposium: Jay Bradner, MD, Opening Remarks
Novartis   2021-07-11 に公開
  In opening remarks for the first NIBR Science of Therapeutics (NSofT) Symposium, NIBR President Jay Bradner welcomes attendees to a “ruthlessly scientific, atomic-level g   ...more
2021 NSofT Symposium: Lynn Connolly, MD, PhD
Novartis   2021-07-11 に公開
  Lynn Connolly, CMO of Adagio Therapeutics, reports on “ADG20: A broadly neutralizing antibody for the prevention and treatment of COVID-19.” Part of the NIBR Science of   ...more
2021 NSofT Symposium: Ashleigh Shannon, PhD
Novartis   2021-07-11 に公開
  Postdoctoral researcher Ashleigh Shannon of University of Aix-Marseille presents, “Nucleoside analogues: Dual targeting of RdRp and NiRAN domains of SARS-CoV nsp12.” Par   ...more
2021 NSofT Symposium: John Bilello, PhD
Novartis   2021-07-11 に公開
  John Bilello, Director of Discovery Virology at Gilead Sciences, describes the “experience in collaboration” behind the development of “Remdesivir in response to the SARS   ...more